A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study

Part of paid clinical trials in Portland, Oregon.

Sponsor: Radboud University Medical Center
Study ID: NCT05906316
Status: Recruiting

Conditions

Mycobacterium Avium Complex Pulmonary Disease

Eligibility Criteria

Sex: ALL
Age: 18 Years - N/A
Healthy Volunteers: Not accepted

Study Details

To gain insight in the effectiveness of, adherence and adjustments to guideline-based three-drug antimycobacterial therapy in patients with Mycobacterium avium complex pulmonary disease (MAC-PD) during the first 6 months of treatment.

Key Dates

Start date: Jul 1, 2023
Status verified: Nov 2024
Primary completion: Jan 1, 2026
Completion: Jul 1, 2026

Study Design

Enrollment: 100 participants (estimated)

Primary Outcome Measure

Culture conversion rate [ Time Frame: 6 months ]

Central Contacts

Arthur Lemson, MSc
+31634265743
[email protected]
Wouter Hoefsloot, MSc, PhD
+31611072569
[email protected]

Locations (1)

Facility	City	State	ZIP	Site coordinators
Oregon Science and Health University	Portland	Oregon	97239	Kevin Winthrop, MD, MPH

Find similar trials in Portland, OR

By research site

Oregon Science and Health University· Portland, OR